We take risks and challenge the status quo because disease must be fought with unexpected practice.
Unlike traditional therapeutic approaches that target growth factors in their active states, Scholar Rock uses its technology platform and structural insights to discover new medicines designed to selectively target the precursor, or inactive, forms of growth factors with the aim of avoiding toxicity and improving efficacy.Learn About Our Science
Scholar Rock works across therapeutic areas and shines new light on the overlooked to better target disease.
Our growing team is replete with good people who eat, sleep, and breathe good science. We promote a spirit of inquiry outside one’s traditional expertise to uncover enlightened solutions for patients.
Our Growing Pipeline
Follow our product candidates on their journeys to fighting serious diseases.
Spinal Muscular Atrophy
Inhibit the activation of latent myostatin to promote a potentially clinically beneficial increase in muscle function
Potential to overcome primary resistance to checkpoint inhibitors to reach a larger patient population
Target RGMc—a co-receptor of BMP6—to potentially treat diseases associated with dysregulation of iron metabolism
Inhibit TGFβ signaling to potentially offer a powerful new approach to suppressing pro-fibrotic signaling in multiple organs
March 15, 2023
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 7, 2023
Scholar Rock Reports Full Year 2022 Financial Results and Highlights Business Progress
March 1, 2023
Scholar Rock to Present 24-Month Data from the Phase 2 TOPAZ trial at the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
EventsView More Events
March 7, 2023
Cowen 43rd Annual Health Care Conference
January 10, 2023
41st Annual J.P. Morgan Healthcare Conference
November 29, 2022
Piper Sandler 34th Annual Healthcare Conference
Let’s talk science, let’s talk you! We’d love to hear from you and answer any questions you may have.
Join Our Team
We’re a group of thinkers and doers who fight disease from a new angle.